1. FDA. Designating an Orphan Product: Drugs and Biological Products. FDA. July 08 2022. Available at https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products [Accessed July 11, 2023].
2. Orphan drug designations as valuable intangible assets for IPO investors in Pharma-Biotech companies;Gorry,2019
3. Review of the impact of the FDA’s fast track designation on biotechnology companies’ share prices;Williamson;Drug Discov Today,2023
4. Do investors value the FDA orphan drug designation?;Miller;Orphanet J Rare Dis,2017
5. Market watch: are orphan drug companies the pick of the pharmaceutical industry?;Morel;Nat Rev Drug Discov,2014